EP
PJP icon

Eudaimonia Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Eudaimonia Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-215
Closed -$17K – 1093
2021
Q1 		$17K Buy
+215
New +$16.8K ﹤0.01% 998

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Eudaimonia Partners's PJP Position: Q2 2021 in Review

Eudaimonia Partners sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2021, closing a stake of 215 shares — an estimated $17K sold.

Eudaimonia Partners first reported a position in PJP in Q1 2021 and held it in 1 quarter. The position peaked at $17K in Q1 2021. 90 funds tracked by Wall St. Rank hold PJP as of Q2 2021.

  • Eudaimonia Partners reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 215 Invesco Pharmaceuticals ETF shares in Q2 2021, an estimated $17K.
  • Eudaimonia Partners first reported a position in Invesco Pharmaceuticals ETF in Q1 2021 and held it in 1 quarter.
  • Eudaimonia Partners's Invesco Pharmaceuticals ETF position peaked at $17K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.